Research Grant (RiGRa)
The RiGra (RIMS Grant Programme) was established to promote excellence and collaboration in Multiple Sclerosis (MS) rehabilitation across Europe. The programme supports projects that aim to advance best practices and research in MS care, encouraging cross-border collaboration and innovation among members of the RIMS community.
Who can apply?
- Applicants must be a RIMS member (either individual or center-level) at the time of submission.
- Submissions must be made electronically (via email) before the announced deadline.
Preferred Criteria
- Applicants under 36 years old (early-career researchers or young clinicians).
- Projects involving multi-center and international collaboration, especially between at least two RIMS centers in different countries.
Judging Criteria
- Clear feasibility and achievable outcomes with the funding provided.
- High relevance to RIMS’ mission and objectives.
- Detailed and transparent budget.
How to apply?
To help you prepare, we invite you to consult last year’s submission form. While details for 2025 will be announced soon, this document offers a valuable reference for expectations and formatting.
RiGra Submission Form
Download documentNext Call for Applications – RiGRa 2026
The next call for applications will be announced in September 2025. The deadline for submissions will be in December 2025. You can see the exact dates in the table below:
📢 Take a look at the winner from 2025 and discover what made their project stand out in this article.
History of RiMS Grant Programme (RiGRa)
- 2024
— Blanca de Dios Perez, University of Nottingham
Measuring value in MS rehabilitation: a comprehensive evaluation framework - 2022
— Philipp Zimmer, TU Dortmund University, Germany
Mechanistic Insights Into Exercise-related Kynurenine Pathway Modulation in Multiple Sclerosis - 2021
— Zuhal Abasıyanık, REVAL Hasselt University, Belgium & Dokuz Eylül University, Izmir, Turkey
Psychometric properties of patient-reported questionnaires assessing dual-task difficulties in daily life in persons with MS: an international multi-center study - 2019
— Anne Rahn, University of Lübeck, Germany
Needs of people with primary progressive multiple sclerosis (NIPS) – a cross-cultural study - 2018
— Giovannetti Ambra
A cross-country validation of the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT) for its use with people with multiple sclerosis – “CompACT for MS” - 2017
— Ruhaak Leonie
Prevalence, features and underlying causes of dysarthria in Multiple Sclerosis: a systematic review